George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

GLOBAL MARKETS-Global stocks advance on coronavirus treatment hopes, dollar slips

Mon, 24th Aug 2020 15:34

(Adds U.S. market open, byline, changes dateline; previous
LONDON)

* S&P 500, Nasdaq set all-time peaks

* Apple shares cross $500 mark, Alibaba also at record high

* Gulf of Mexico storms lift crude oil futures

* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E

By Herbert Lash

NEW YORK, Aug 24 (Reuters) - The dollar slid but a gauge of
global equity markets advanced on Monday, driven by coronavirus
treatment hopes that bolstered risk sentiment and lifted the S&P
500 and Nasdaq to all-time peaks.

Apple Inc rose 0.9% to cross $500 per share for the
first time, while Chinese retailer Alibaba's U.S.-listed shares
climbed 3.3%, to a record high. Shares of electric
carmaker also set a new high before falling -3.3%.

The U.S. Food and Drug Administration's move to use
anti-body rich plasma from recovered patients was hailed by
President Donald Trump and came a day after he accused the FDA
of impeding the roll-out of treatments for political reasons.

The announcement came on the eve of the Republican National
Convention, where Trump will be nominated as the party's
candidate for the presidency for four more years.

Markets also geared up for the U.S. Federal Reserve's annual
Jackson Hole meeting later in the week.

Europe's broad FTSEurofirst 300 index added 1.48%
to 1,437.53, while MSCI's benchmark for global equity markets
rose 0.94% to 576.33 after overnight gains in
Asia.

On Wall Street, the Dow Jones Industrial Average rose
0.95%, the S&P 500 gained 0.74% and the Nasdaq Composite
added 0.51%.

"Vaccine news are giving equities another global boost,
despite the worsening in infection rates observed in many
jurisdictions," said Citi's Luis Costa.

U.S. regulators on Sunday authorized the use of blood plasma
from recovered patients as a treatment option and AstraZeneca
rose on a Financial Times report that the U.S. government was
considering fast-tracking its experimental vaccine.

AstraZeneca rose 3.0%, providing the FTSE 100
index in London its biggest boost.

Safe-haven German bond yields rose after their longest
decline this year as hopes for a coronavirus treatment boosted
risk appetite. German 10-year bunds yielded -0.505%.

In currency markets the dollar dipped but held above
two-year lows against the euro. Federal Reserve Chairman Jerome
Powell this week will give a highly anticipated speech about the
U.S. central bank's policy framework review.

A sharp dollar sell-off against the euro has paused, with
the greenback getting a boost on Friday after data showed a
recovery in U.S. business conditions, while European data showed
slowing improvement.

The dollar index fell 0.086%, with the euro up
0.19% to $1.1818.

The Japanese yen was flat versus the greenback at
105.81 per dollar.

Crude oil prices rose as storms closed in on the Gulf of
Mexico, shutting more than half its oil production, and on signs
of progress in development of COVID-19 treatments.

Brent crude futures rose $0.52, to $44.87 a barrel.
U.S. crude futures gained $0.28, to $42.62 a barrel.

Gold prices rose as the dollar dipped, making bullion
cheaper for holders of other currencies, but hopes for progress
in the treatment of COVID-19 limited gains in the safe-haven
metal.

Spot gold prices fell -0.12% to $1,937.15 an ounce.

(Reporting by Herbert Lash; Editing by Dan Grebler)

Related Shares

More News
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the...

27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downt...

27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the w...

27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation readin...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.